Suppr超能文献

衔接蛋白SLP-65作为一种肿瘤抑制因子,可限制前B细胞的扩增。

The adaptor protein SLP-65 acts as a tumor suppressor that limits pre-B cell expansion.

作者信息

Flemming Alexandra, Brummer Tilman, Reth Michael, Jumaa Hassan

机构信息

Institute for Biology III, Albert-Ludwigs University of Freiburg and Max Planck Institute for Immunobiology, Stuebeweg 51, 79108 Freiburg, Germany.

出版信息

Nat Immunol. 2003 Jan;4(1):38-43. doi: 10.1038/ni862. Epub 2002 Nov 18.

Abstract

Mice deficient in the adaptor protein SLP-65 (also known as BLNK) have reduced numbers of mature B cells, but an increased pre-B cell compartment. We show here that compared to wild-type cells, SLP-65(-/-) pre-B cells show an enhanced ex vivo proliferative capacity. This proliferation requires interleukin 7 and expression of the pre-B cell receptor (pre-BCR). In addition, SLP-65(-/-) mice have a high incidence of pre-B cell lymphoma. Reintroduction of SLP-65 into SLP-65(-/-) pre-B cells led to pre-BCR down-regulation and enhanced differentiation. Our results indicate that SLP-65 regulates a developmental program that promotes differentiation and limits pre-B cell expansion, thereby acting as a tumor suppressor.

摘要

衔接蛋白SLP-65(也称为BLNK)缺陷的小鼠成熟B细胞数量减少,但前B细胞区室增加。我们在此表明,与野生型细胞相比,SLP-65(-/-)前B细胞在体外显示出增强的增殖能力。这种增殖需要白细胞介素7和前B细胞受体(pre-BCR)的表达。此外,SLP-65(-/-)小鼠前B细胞淋巴瘤的发病率很高。将SLP-65重新引入SLP-65(-/-)前B细胞导致pre-BCR下调并增强分化。我们的结果表明,SLP-65调节促进分化并限制前B细胞扩增的发育程序,从而起到肿瘤抑制作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验